Omalizumab in Severe Allergic Asthma Inadequately Controlled With Standard TherapyNicola A. Hanania, William W. Busse, Irmarie Reyes‐Rivera et al.|Annals of Internal Medicine|2011Cited by 550
Incidence of malignancy in patients with moderate-to-severe asthma treated with or without omalizumabAidan A. Long, Stanley J. Szefler, Abdelkader Rahmaoui et al.|Journal of Allergy and Clinical Immunology|2014Cited by 222